| Literature DB >> 32974263 |
Renata Sisto1, Delia Cavallo1, Cinzia Lucia Ursini1, Anna Maria Fresegna1, Aureliano Ciervo1, Raffaele Maiello1, Enrico Paci1, Daniela Pigini1, Monica Gherardi1, Andrea Gordiani1, Nunziata L'Episcopo1, Giovanna Tranfo1, Pasquale Capone1, Damiano Carbonari1, Barbara Balzani2, Pieranna Chiarella1.
Abstract
Volatile organic compounds (VOCs) are present in several working activities. This work is aimed at comparing oxidative stress and DNA damage biomarkers to specific VOCs in the occupational exposure of painters. Dose-response relationships between biomarkers of oxidative stress and of dose were studied. Unmetabolized VOCs and their urinary metabolites were analyzed. Urinary Methylhyppuric acids (MHIPPs, xylenes metabolite), Phenylglyoxylic and Mandelic acid (PGA, MA ethylbenzene metabolites), S-Benzylmercapturic acid (SBMA, toluene metabolite), and S-Phenylmercapturic acid (SPMA, benzene metabolite) were quantified at the end of work-shift. Oxidative stress was determined by: urinary excretion of 8-oxodGuo, 8-oxoGua and 8-oxoGuo and direct/oxidative DNA damage in blood by Fpg-Comet assay. Multivariate linear regression models were used to assess statistical significance of the association between dose and effect biomarkers. The regressions were studied with and without the effect of hOGG1 and XRCC1 gene polymorphisms. Statistically significant associations were found between MHIPPs and both 8-oxoGuo and oxidative DNA damage effect biomarkers measured with the Comet assay. Oxidative DNA damage results significantly associated with airborne xylenes and toluene, whilst 8-oxodGuo was significantly related to urinary xylenes and toluene. Direct DNA damage was significantly associated to SBMA. XRCC1 wild-type gene polymorphism was significantly associated with lower oxidative and total DNA damage with respect to heterozygous and mutant genotypes. The interpretation of the results requires some caution, as the different VOCs are all simultaneously present in the mixture and correlated among them.Entities:
Keywords: biological monitoring; gene polymorphism; genotoxicity; oxidative stress; urinary dose biomarkers; volatile organic compounds
Year: 2020 PMID: 32974263 PMCID: PMC7469480 DOI: 10.3389/fpubh.2020.00445
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Characteristic of the subjects with polymorphisms of the analyzed genes.
| N1 | Roller | NO | wt | wt |
| N2 | Roller | YES | wt | wt |
| N3 | Roller | NO | het | het |
| N5 | Roller | NO | mut | het |
| N7 | Roller | NO | het | mut |
| N10 | Roller | NO | het | het |
| N11 | Roller | NO | wt | mut |
| N12 | Roller | YES | wt | wt |
| N13 | Roller | NO | het | het |
| N15 | Roller | na | wt | wt |
| N16 | Roller | NO | wt | wt |
| N4 | Spray | YES | wt | wt |
| N6 | Spray | NO | wt | wt |
| N8 | Spray | NO | mut | wt |
| N9 | Spray | YES | wt | wt |
| N17 | Spray | YES | mut | het |
| N18 | Spray | NO | wt | het |
Wt, wild type; het, heterozygous; mut, homozygous mutant.
VOCs' metabolites concentrations in the end – shift urine.
| Mean | 7.33 | 4.40 | 1.73 | 12.33 | 57.31 | 14.70 |
| Median | 7.68 | 4.56 | 1.82 | 13.00 | 60.04 | 15.24 |
| SD | 8.09 | 4.75 | 1.66 | 13.73 | 63.21 | 15.40 |
| 5th perc | 8.49 | 4.94 | 1.75 | 14.46 | 66.19 | 16.00 |
| 25th perc | 8.50 | 4.81 | 1.87 | 14.69 | 65.85 | 15.90 |
| 75th perc | 8.62 | 4.24 | 1.96 | 14.93 | 65.16 | 16.12 |
| 95th perc | 8.94 | 4.42 | 2.08 | 15.67 | 67.13 | 16.67 |
| Max | 9.38 | 4.63 | 2.17 | 16.28 | 69.78 | 16.62 |
| Min | 7.93 | 4.30 | 1.81 | 13.44 | 65.49 | 16.55 |
The metabolites 3 and 4 methtylhyppuric acids are not separated by the chromatographic process. However, the occupational exposure limit value refer to the sum of the three metabolites.
Urinary unchanged VOCs concentrations in the end – shift urine.
| Mean | 463.9 | 20.9 | 62.0 | 6.1 | 32.2 | 27.6 | 101.9 | 56.4 |
| Median | 58.8 | 6.5 | 11.9 | 4.0 | 10.1 | 6.9 | 34.1 | 25.5 |
| SD | 1252.7 | 39.1 | 169.9 | 6.5 | 63.1 | 59.1 | 201.3 | 83.3 |
| 5th perc | 27.8 | 2.5 | 6.0 | 2.4 | 3.3 | 1.0 | 13.0 | 13.1 |
| 25th perc | 41.8 | 3.5 | 8.4 | 3.1 | 7.0 | 4.0 | 22.2 | 18.9 |
| 75th perc | 103.3 | 17.6 | 16.4 | 6.5 | 15.8 | 8.3 | 48.7 | 39.4 |
| 95th perc | 2505.0 | 73.4 | 271.9 | 15.6 | 160.8 | 168.1 | 496.4 | 223.6 |
| Max | 5015.3 | 163.2 | 688.5 | 29.5 | 242.6 | 205.8 | 788.0 | 333.2 |
| Min | 23.8 | 2.4 | 5.9 | 2.1 | 2.6 | 0.7 | 12.8 | 12.9 |
Biomarkers of direct and oxidative damage to the DNA.
| Mean | 17.68 | 5.67 | 26.85 | 22.39 | 7.87 | 37.40 | 4.71 | 2.20 | 10.55 | 11.21 | 16.13 | 5.53 |
| Median | 16.30 | 5.68 | 27.50 | 22.70 | 7.93 | 39.00 | 4.30 | 2.03 | 10.20 | 6.20 | 14.72 | 5.59 |
| SD | 4.35 | 1.76 | 7.05 | 4.39 | 1.48 | 7.12 | 3.07 | 0.95 | 5.16 | 13.69 | 6.12 | 1.90 |
| 5th perc | 12.42 | 3.34 | 18.51 | 15.68 | 5.51 | 25.68 | 0.48 | 1.08 | 4.93 | 0.01 | 10.04 | 3.28 |
| 25th perc | 15.30 | 4.22 | 20.71 | 18.90 | 7.60 | 33.30 | 2.10 | 1.53 | 5.70 | 0.83 | 11.20 | 4.05 |
| 75th perc | 20.90 | 7.23 | 29.80 | 24.43 | 8.60 | 40.60 | 6.50 | 2.66 | 12.90 | 14.84 | 18.33 | 5.98 |
| 95th perc | 24.42 | 8.09 | 35.76 | 28.60 | 9.83 | 44.96 | 9.6 | 3.70 | 19.55 | 32.53 | 28.30 | 8.17 |
| Max | 26.50 | 8.32 | 44.00 | 31.40 | 10.35 | 54.00 | 11.60 | 4.09 | 20.30 | 46.63 | 31.16 | 10.71 |
| Min | 10.50 | 2.94 | 14.80 | 15.60 | 5.17 | 24.40 | 0.40 | 0.58 | 3.69 | 0.01 | 9.94 | 2.99 |
AU, arbitrary units.
Figure 1Statistical distribution of the DNA percentage difference, representing the oxidative damage to the DNA in the three different genotypes of the XRCC1 gene. The wild type is significantly lower than the mutant genotype. The variant of the XRCC1 with respect to the wild type are disadvantageous types, both the heterozygous and the mutant.
Correlation matrix of the dose biomarkers: VOCs metabolites measured in urine, airborne and urinary VOCs concentrations.
| MA (μg/g cr) | 1.00 | 0.63 | 0.73 | 0.15 | 0.37 | 0.31 | 0.03 | 0.48 | 0.53 | 0.69 | 0.35 | 0.51 | 0.53 | |
| PGA (μg/g cr) | 1.00 | 0.32 | 0.66 | 0.07 | 0.20 | 0.16 | −0.06 | 0.18 | 0.24 | 0.32 | 0.46 | 0.28 | 0.28 | |
| SPMA (μg/g cr) | 1.00 | 0.72 | 0.15 | 0.53 | 0.59 | −0.03 | 0.54 | 0.54 | 0.54 | 0.30 | 0.28 | 0.31 | ||
| MHIPP (μg/g cr) | 1.00 | 0.20 | 0.61 | 0.58 | −0.09 | 0.71 | 0.73 | 0.51 | 0.55 | 0.54 | 0.56 | |||
| SBMA (μg/g cr) | 1.00 | 0.59 | 0.52 | −0.29 | 0.42 | 0.38 | 0.23 | −0.25 | −0.18 | −0.12 | ||||
| Ethylacetate (mg/m3) | 1.00 | −0.07 | 0.28 | 0.40 | 0.23 | 0.30 | ||||||||
| Toluene (mg/m3) | 1.00 | −0.17 | 0.02 | 0.45 | 0.09 | 0.15 | ||||||||
| n_butyl-acetate (mg/m3) | 1.00 | 0.20 | 0.24 | −0.04 | 0.69 | |||||||||
| Ethylbenzene (mg/m3) | 1.00 | 0.27 | 0.75 | 0.59 | 0.62 | |||||||||
| Xylenes (mg/m3) | 1.00 | 0.30 | 0.65 | 0.69 | ||||||||||
| Benzene (μg/g cr) | 1.00 | −0.11 | 0.74 | 0.73 | ||||||||||
| Toluene (μg/g cr) | 1.00 | |||||||||||||
| Ethylbenzene (μg/g cr) | 1.00 | |||||||||||||
| Xylenes_ (μg/g cr) | 1.00 |
Statistical association between the dose biomarkers and the biomarkers of oxidative stress.
| TLenz – buffer | MHIPPs | MHIPPs | MHIPPs | |
| 8-oxoGuo | Ns | MHIPPs | ||
| TLenz – buffer | Airborne xylenes (mg/m3) | Air_xylenes | Air_xylenes | |
| TLenz – buffer | Airborne toluene (mg/m3) | Air_toluene | Air_toluene | |
| TLenz – buffer | Airborne ethylbenzene (mg/m3) | Air ethylbenzene | Air_ethylbenzene | |
| TLenz – buffer | Airborne ethylacetate (mg/m3) | Air ethylacetate | Air ethylacetate | |
| 8-oxodGuo | Urine p-xylene | Ns | ns | |
| 8-oxodGuo | Urine toluene | Ns | ns |
The model (1) was fitted with or without the polymorphisms.
Statistical association between dose biomarkers and biomarkers of direct DNA damage.
| TM | SBMA | 0.045 | 0.13 | 0.06 |
| Tail DNA % | 0.023 | 0.36 | 0.14 | |
| TL (μm) | Urine toluene | 0.037 | −0.022 | 0.009 |
Figure 2Linear association between the S-Benzylmercapturic acid concentration and percentage of the DNA in the tail used as biomarker of direct damage to the DNA.
Statistical association between dose biomarkers and biomarkers of total (direct and oxidative) damage to the DNA.
| TLenz | MHIPPs | ns | MHIPPs |
| TMenz | SBMA | ns | SBMA |
| Tail DNA% enz | SBMA |
Only the significant relations are reported. The model (1) was fitted with and without the polymorphism of the gene XRCC1.
Figure 3Statistical distribution of the tail moment with enzyme, representing the total DNA damage, direct and oxidative in the three different genotypes of the XRCC1 gene. The wild type is significantly lower than the heterozygous and the mutant genotypes. The difference between mutant and heterozygous is not statistically significant. The variant of the XRCC1 with respect to the wild type are disadvantageous types, both the heterozygous and the mutant.
Figure 4Linear association between the tail length in presence of the formamidopyrimidine glycosylase enzyme and the 8-oxoGuo concentration. The statistical association between the two variables is statistically significant (p = 0.042).